methyl N-[(2S)-1-[[(2S,3S)-3-hydroxy-4-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-[(4-pyridin-2-ylphenyl)methyl]amino]-1-phenylbutan-2-yl]amino]-3,3-dimethyl-1,4-dioxobutan-2-yl]carbamate structure
|
Common Name | methyl N-[(2S)-1-[[(2S,3S)-3-hydroxy-4-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-[(4-pyridin-2-ylphenyl)methyl]amino]-1-phenylbutan-2-yl]amino]-3,3-dimethyl-1,4-dioxobutan-2-yl]carbamate | ||
---|---|---|---|---|
CAS Number | 1463472-89-0 | Molecular Weight | 718.83900 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C38H50N6O8 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Name | methyl N-[(2S)-1-[[(2S,3S)-3-hydroxy-4-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-[(4-pyridin-2-ylphenyl)methyl]amino]-1-phenylbutan-2-yl]amino]-3,3-dimethyl-1,4-dioxobutan-2-yl]carbamate |
---|---|
Synonym | More Synonyms |
Molecular Formula | C38H50N6O8 |
---|---|
Molecular Weight | 718.83900 |
Exact Mass | 718.36900 |
PSA | 202.25000 |
LogP | 5.48000 |
Atazanavir metabolite M13 |
2,5,6,10,13-Pentaazatetradecanedioic acid,3-(1,1-dimethylethyl)-12-(1,1-dimethyl-2-oxoethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-,1,14-dimethyl ester,(3S,8S,9S,12S) |